This highlights the exciting potential of manipulating ABHD11 function for therapeutic benefit in T-cell-mediated autoimmune disease, where reversing the hyper-activation and -function of pathogenic T-cells would be valuable. The gene discussed is ABHD11; the disease is autoimmune disease.